22157.jpg
Neurological Biomarkers Market by Application, by Type, by End-use, by Region and Forecasts to 2028
December 06, 2021 06:58 ET | Research and Markets
Dublin, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The "Neurological Biomarkers Market Size, Share & Trends Analysis Report By Application (Alzheimer's, Parkinson's), By Type (Genomic, Proteomic), By...
22157.jpg
Outlook on the Neurological Diseases Treatment Global Market to 2029 - Key Drivers, Challenges and Opportunities
April 29, 2021 07:18 ET | Research and Markets
Dublin, April 29, 2021 (GLOBE NEWSWIRE) -- The "Neurological Diseases Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies...
22157.jpg
Insights on the Genetic Testing for Epilepsy, Autism, Alzheimer's and Other Neurologic Conditions Global Market to 2025
February 15, 2021 05:43 ET | Research and Markets
Dublin, Feb. 15, 2021 (GLOBE NEWSWIRE) -- The "Genetic Testing Markets for Epilepsy, Autism, Alzheimer's and Other Neurologic Conditions" report has been added to ResearchAndMarkets.com's offering. ...
Gala Logo.jpg
Gala Global to Finalize Initial Hemp "CBD" Products
February 11, 2015 08:00 ET | Gala Pharmaceutical Inc.
LOS ANGELES, Feb. 11, 2015 (GLOBE NEWSWIRE) -- Gala Global, Inc. (OTCQB:GLAG) today announced it has finalized the initial CBD products. The initial products will based on flavored infused CBD Oral...